Suzano Q2 2026: EBITDA Jumps, Tissue JV Deal Boosts Growth Outlook
Suzano posted stronger Q2 2026 results with higher EBITDA, net income and pulp/paper volumes despite FX and oil cost pressures. It also finalized a $1.3B tissue JV acquisition with Kimberly-Clark.